1 / 26

Clin Med II Infectious Disease

Clin Med II Infectious Disease. Lecture II—Viral Diseases, part 1/3. Cytolomegalovirus. Cytomegalovirus. Usually asymptomatic Seroprevalence 60-80% in Western countries Transmission sexual contact breast feeding blood products transplantation person-to-person congenital.

cayla
Télécharger la présentation

Clin Med II Infectious Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clin Med II Infectious Disease Lecture II—Viral Diseases, part 1/3

  2. Cytolomegalovirus

  3. Cytomegalovirus • Usually asymptomatic • Seroprevalence 60-80% in Western countries • Transmission • sexual contact • breast feeding • blood products • transplantation • person-to-person • congenital

  4. Congenital CMV • Most common congenital infection in developed countries—0.2%-2% of all live births • 10% of infected newborns will be symptomatic with CMV inclusion disease

  5. CMV in Immunocompetent • Most common cause of acute mononucleosis-like syndrome with negative heterophil antibodies • Critically ill—reactivated • Associated with multiple diseases but link is unclear • IBD • Atherosclerosis • Cognitive decline

  6. CMV in Immunocompromised • Tissue and bone marrow transplant patients • CMV is immunosuppressive • Can contribute to transplanted organ dysfunction • HIV patients

  7. Perinatal and CMV Inclusion • Jaundice and HSM • Thrombocytopenia and purpura • Microcephaly, periventricular CNS calcifications, mental retardation and motor disability • Hearing loss in > 50% symptomatic at birth • Most infected are asymptomatic but develop neurological deficits later on

  8. CMV in Immunocompetent • Fever, malaise, myalgias, arthralgias, splenomegaly • Cutaneous rashes • Complications—mucosal GI damage, encephalitis, hepatitis, thrombocytopenia, Guillain-Barré, pericarditis, myocarditis

  9. CMV in Immunocompromised • Distinguish between CMV infection and CMV disease • Patients at risk—HIV, organ transplant, stem cell transplant • CMV viral loads correlate with prognosis after transplantation

  10. CMV in Immunocompromised • Retinitis—neovascular, proliferative lesions • GI/Hepatobiliary—odynophagia, gastritis, small bowel disease, colonic disease, liver transplant complications • Respiratory—pneumonitis • Neurologic—polyradiculopathy, transverse myelitis, ventriculoencephalitis, focal encephalitis

  11. Cytomegalovirus • Mothers and Newborns—pregnant women tested for IgM CMV antibodies q 3 mo if positive assay in 1sttrimiester • PCR assays of dried blood samples from newborns and micro-ELISA on urine, saliva or blood specimens during 1st 3 weeks of life to diagnose congenital CMV • Immunocompetent—initial leukopenia followed by absolute lymphocytosis with atypical lymphocytes • abnormal LFTs • CMV specific IgM or 4x increase in specific IgG • Immunocompromised—serology, cultures, PCR, pp65 antigen and viral load; rapid shell-viral cultures • CXR—consistent with interstitial pneumonia • Biopsy—especially useful in pneumonitis and GI disease

  12. Cytomegalovirus • Retinitis—IV ganciclovir if sight-threatening; less severe disease, oral valganciclovir • Other infections—same antivirals; length of therapy depends on how immunosuppressed the pt is • CMV from transplant—ganciclovir (at same doses as retinis) for 2-3 weeks • Pregnancy—passive immunization with hyperimmune globulin • Prevention—no current vaccine; HAART prevents in HIV-infected patients

  13. Cytomegalovirus • Refer • neonatal infections consistent with CMV inclusion disease • AIDS + retinitis, esophagitis, colitis, encephalitis • AIDS + hepatobiliary disease • Organ or hematopoietic stem cell transplants with suspected CMV reactivation • Admit • Risk of colonic perforation • Unexplained, advancing encephalopathy • Biopsy of tissues • Initiation of IV anti-CMV agents

  14. Epstein-Barr Virus

  15. Epstein-Barr Virus • Also known as human herpesvirus type 4 • Infects >90% of population worldwide and persists for lifetime of host • Mainly transmitted by saliva but can also be recovered from genital secretions

  16. Epstein-Barr Virus • Early—fever, sore throat, fatigue, malaise, anorexia, myalgia • Lymphadenopathy, splenomegaly, rash • Conjunctival hemorrhage, pharyngitis, tonsillitis, gingivitis, soft palate petechiae • Can see other organ system involvement as well

  17. Epstein-Barr Virus • Labs—granulocytopenia followed within 1 week by a lymphocytic leukocytosis with atypical lymphocytes comprising over 10% of leukocyte count • May see hemolytic anemia or thrombocytopenia • Monospot test, IgM and IgG titers • PCR – useful for malignancies associated with EBV

  18. Epstein-Barr Virus • Over 95% of patients with acute disease recover without specific antiretroviral therapy • Symptomatic—acetaminophen or NSAIDs, warm salt-water gargles TID-QID • Hepatitis, myocarditis, and encephalitis—symptomatic • Splenic rupture—splenectomy • Avoid contact sports for at least 4 weeks • Prognosis good in uncomplicated cases • fever resolves in 10 days • lymphadenopathy and splenomegaly resolve in 4 weeks • debility can linger for 2-3 months

  19. ErythemaInfectiosum

  20. Erythrovirus Infections • Parvovirus B19 • Widespread • Respiratory secretions, saliva, placenta, blood products • Incubation 4-14 days

  21. ErythemaInfectiosum • Children—exanthematous illness, erythemainfectiosum • Fiery red cheeks • Circumoral pallor • Lacy maculopapular rash on extremities • Malaise, headache, and pruritis

  22. ErythemaInfectiosum

  23. Erythrovirus Infections • Immunocompromised—transient aplastic crisis and pure red blood cell aplasia • Adults—limited nonerosive symmetric polyarthritis • Chloroquine—exacerbates erythrovirus-related anemia • Pregnancy—premature labor, hydropsfetalis, fetal loss

  24. Erythrovirus Infections • Clinical diagnosis may be confirmed by elevated anti-erythrovirusIgM (serum) or with PCR (serum or marrow) • Complications—rare • Treatment is symptomatic in healthy patients • Immunosuppressed patients—IVIG • Intrauterine transfusion—severe fetal anemia • Prevention—screening donated blood, standard containment guidelines in nosocomial outbreaks • Prognosis—excellent in immunocompetent patients

  25. Questions?

More Related